AngioDynamics Reports Fiscal 2016 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
AngioDynamics (ANGO) PT Cut at Piper Jaffray
January 8, 2016 7:34 AM ESTAngioDynamics (NASDAQ: ANGO) met expectations for its Q2 (Nov) revenues and earnings, but cut guidance for the remainder of the year as the vascular access business has been adjusting to a Q3 recall from last year. Piper Jaffray analyst, Thomas Gunderson, lowered numbers as a result.
The Morpheus product was taken off the market, and the sales force diverted effort to try to retain customers. Not only was retention more... More
AngioDynamics (ANGO) Reports In-Line Q2 EPS; Trims FY16 Outlook
January 7, 2016 4:05 PM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $89.2 million versus the consensus estimate of $88.67 million.
GUIDANCE:
AngioDynamics sees Q3 2016 EPS of $0.10-$0.14, versus the consensus of $0.17. AngioDynamics sees... More
